Zealand Stock Price Prediction

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:3em;padding-top: 40px;;'>ZEA</div>
ZEAL -- Denmark Stock  

DKK 216.60  13.00  6.39%

Zealand Pharma Return on Investment is quite stable at the moment as compared to the last year. The company current value of Return on Investment is estimated at about 71.16. Revenue to Assets is projected to rize to 0.036447 this year, although the value of Operating Margin will most likelly fall to (58.14) . We analyze noise-free headlines and recent hype associated with Zealand Pharma AS, which may create opportunities for some arbitrage if properly timed. Check out Zealand Pharma Basic Forecasting Models to cross-verify your projections.
View Stock Price Prediction For
The Zealand stock price prediction module also provides an analysis of price elasticity to changes in media outlook on Zealand Pharma over a specific investment horizon. Using Zealand Pharma hype-based prediction, you can estimate the value of Zealand Pharma AS from the perspective of Zealand Pharma response to recently generated media hype and the effects of current headlines on its competitors.

Zealand Pharma After-Hype Price Density Analysis

 Next price density 
  Expected price to next headline 

Zealand Pharma Estimiated After-Hype Price Volatility

Current Value
April 2, 2020
After-hype Price
Zealand Pharma is very steady asset. Analysis and calculation of next after-hype price of Zealand Pharma AS is based on 3 months time horizon.

Zealand Pharma Stock Price Prediction Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.09  5.49  0.22   0.03  2 Events / Month0 Events / MonthIn a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Zealand Pharma Hype Timeline

Zealand Pharma AS is at this time traded for 216.60on Copenhagen Stock Exchange of Denmark. The entity has historical hype elasticity of 0.22 and average elasticity to hype of competition of 0.03. Zealand Pharma AS is anticipated to increase in value after the next headline with price going to jump to 216.82. The average volatility of media hype impact on the company stock price is about 228.75%. The price increase on the next news is estimated to be 0.1% where as daily expected return is at this time at 0.09%. The volatility of related hype on Zealand Pharma is about 1601.25% with expected price after next announcement by competition of 216.63. The company reported revenue of 42.96 M. Net Loss for the year was (508.24 M) with profit before overhead, payroll, taxes, and interest of 40.92 M. Assuming 30 trading days horizon, the next anticipated press release will be in a few days.
Check out Zealand Pharma Basic Forecasting Models to cross-verify your projections.

Zealand Pharma Related Hype Analysis

Check out Zealand Pharma Basic Forecasting Models to cross-verify your projections. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page